Market open· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) CEO John Shaw joined Steve Darling from Proactive to discuss the company's strong first-half performance, highlighted by breakeven adjusted EBITDA, a stronger cash position, and continued revenue growth as demand for its sustainable polymer technologies expands across key markets. Shaw said the company's progress can be measured by three critical metrics moving in the right direction simultaneously: revenue growth, profitability, and cash generation. Achieving breakeven adjusted EBITDA marks an important milestone for Itaconix as it continues to sc
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) says its SLAB gene therapy trial in ageing dogs has hit its primary endpoint. It's now in talks with major animal health companies about a licensing deal. EnergyPathways PLC (AIM:EPP) has appointed Jacobs as engineering and regulatory partner for its MESH energy storage project in the Irish Sea. It's now pushing towards a key Ofgem funding submission. Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) is targeting a doubling of revenue to $30 million in the medium term. Half-year revenue already jumped 72% thanks to strong detergent demand. G
Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0), the AIM-listed maker of plant-based specialty polymers used in household detergents, has reiterated its recently upgraded revenue guidance, unveiling plans to more than double revenues to $30 million in the medium term. The company also said it...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.